ARCHIVES

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996